ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FUM Futura Medical Plc

35.45
0.05 (0.14%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.14% 35.45 35.20 35.60 35.65 35.20 35.45 246,675 16:35:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.14 105.85M

Futura Medical PLC Notification of Half Year Results (0494F)

25/07/2016 7:00am

UK Regulatory


Futura Medical (LSE:FUM)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Futura Medical Charts.

TIDMFUM

RNS Number : 0494F

Futura Medical PLC

25 July 2016

For immediate release 25 July 2016

Futura Medical plc

("Futura" or "the Company")

Notification of Half Year Results

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its interim results for the six months ended 30 June 2016 on Tuesday 13 September 2016.

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

There will be a live webcast of the analyst presentation. If you would like to listen to the webcast, please log on to the following web address approximately 5 minutes before 10.00am on the day of results: http://vm.buchanan.uk.com/2016/futuramedical130916/registration.htm

A recording of the webcast will also be made available at www.futuramedical.com and www.buchanan.uk.com following the results meeting.

To register attendance at the meeting, please contact Buchanan on 020 7466 5000.

For further information please contact:

 
 Futura Medical plc 
 James Barder, Chief Executive              Tel: +44 (0) 1483 685 670 
 Email to: james.barder@futuramedical.com   www.futuramedical.com 
 
 N+1 Singer (Nominated Adviser 
  and Broker) 
 Aubrey Powell / Liz Yong                   Tel:+44 (0) 20 7496 3000 
 
 For media enquiries please contact: 
 Buchanan 
 Mark Court / Sophie Cowles /               Tel: +44 (0) 20 7466 5000 
  Stephanie Watson 
 

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORUUUNRNRABUAR

(END) Dow Jones Newswires

July 25, 2016 02:00 ET (06:00 GMT)

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Your Recent History

Delayed Upgrade Clock